FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1697395551> ?p ?o ?g. }

• W1697395551 endingPage "559" @default.
• W1697395551 startingPage "553" @default.
• W1697395551 abstract "Individuals suffering from an alcohol-use disorder (AUD) constitute a major health concern. Preclinical studies in our laboratory show that acute and chronic intraperitoneal (i.p.) administration of ivermectin (IVM) reduces alcohol intake and preference in mice. To enable clinical investigation to use IVM for the treatment of an AUD, development of an oral formulation that can be used in animals as well as long-term preclinical toxicology studies are required. The present work explores the use of a promising alternative dosage form of IVM, fast-dissolving oral films (Cure Pharmaceutical®), to test the efficacy and safety of oral IVM in conjunction with alcohol exposure. We tested the effect of IVM (0.21 mg) using a fast-dissolving oral film delivery method on reducing 10% v/v alcohol (10E) intake in female C57BL/6 mice using a 24-h access two-bottle choice paradigm for 6 weeks (5 days per week). Differences in ethanol intake, preference for ethanol, water intake, fluid intake, food intake, changes in mouse and organ weights, as well as histological changes to kidney, liver, and brain were analyzed. The IVM group drank significantly less ethanol over the 30-day period compared to the placebo (blank strip) and the no-treatment groups. Organ weights did not differ between the groups. Histological evaluation showed no differences in the brain and kidney between groups. In the liver, there was a slight increase in the incidence of microvesicular fatty and degenerative changes of the animals receiving the thin strips. No overt hepatocellular necrosis or perivascular inflammation was noted. Overall, these data support the use of this novel method of oral drug delivery for longer-term studies and should facilitate FDA required preclinical testing that is necessary to repurpose IVM for treatment of an AUD." @default.
• W1697395551 created "2016-06-24" @default.
• W1697395551 creator A5016253604 @default.
• W1697395551 creator A5023856434 @default.
• W1697395551 creator A5047373416 @default.
• W1697395551 creator A5067739581 @default.
• W1697395551 creator A5071431222 @default.
• W1697395551 date "2015-09-01" @default.
• W1697395551 modified "2023-09-25" @default.
• W1697395551 title "Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder" @default.
• W1697395551 cites W1490568823 @default.
• W1697395551 cites W1529431456 @default.
• W1697395551 cites W1594627772 @default.
• W1697395551 cites W1959467500 @default.
• W1697395551 cites W1968658503 @default.
• W1697395551 cites W1969898647 @default.
• W1697395551 cites W1976054510 @default.
• W1697395551 cites W1978341764 @default.
• W1697395551 cites W1994355761 @default.
• W1697395551 cites W1995494541 @default.
• W1697395551 cites W1995953023 @default.
• W1697395551 cites W2011005824 @default.
• W1697395551 cites W2024865914 @default.
• W1697395551 cites W2034788081 @default.
• W1697395551 cites W2055920458 @default.
• W1697395551 cites W2057264061 @default.
• W1697395551 cites W2057621975 @default.
• W1697395551 cites W2068482739 @default.
• W1697395551 cites W2082206299 @default.
• W1697395551 cites W2086730289 @default.
• W1697395551 cites W2090498136 @default.
• W1697395551 cites W2109097527 @default.
• W1697395551 cites W2111863516 @default.
• W1697395551 cites W2129382029 @default.
• W1697395551 cites W2133497175 @default.
• W1697395551 cites W2146030214 @default.
• W1697395551 cites W2149040036 @default.
• W1697395551 cites W2149232781 @default.
• W1697395551 cites W2150215474 @default.
• W1697395551 cites W2153001824 @default.
• W1697395551 cites W2161776461 @default.
• W1697395551 cites W2169784685 @default.
• W1697395551 cites W2291966787 @default.
• W1697395551 cites W2398396845 @default.
• W1697395551 cites W4237397855 @default.
• W1697395551 doi "https://doi.org/10.1016/j.alcohol.2015.03.006" @default.
• W1697395551 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4554813" @default.
• W1697395551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26095588" @default.
• W1697395551 hasPublicationYear "2015" @default.
• W1697395551 type Work @default.
• W1697395551 sameAs 1697395551 @default.
• W1697395551 citedByCount "12" @default.
• W1697395551 countsByYear W16973955512016 @default.
• W1697395551 countsByYear W16973955512017 @default.
• W1697395551 countsByYear W16973955512018 @default.
• W1697395551 countsByYear W16973955512019 @default.
• W1697395551 countsByYear W16973955512020 @default.
• W1697395551 countsByYear W16973955512021 @default.
• W1697395551 countsByYear W16973955512022 @default.
• W1697395551 countsByYear W16973955512023 @default.
• W1697395551 crossrefType "journal-article" @default.
• W1697395551 hasAuthorship W1697395551A5016253604 @default.
• W1697395551 hasAuthorship W1697395551A5023856434 @default.
• W1697395551 hasAuthorship W1697395551A5047373416 @default.
• W1697395551 hasAuthorship W1697395551A5067739581 @default.
• W1697395551 hasAuthorship W1697395551A5071431222 @default.
• W1697395551 hasBestOaLocation W16973955512 @default.
• W1697395551 hasConcept C126322002 @default.
• W1697395551 hasConcept C142724271 @default.
• W1697395551 hasConcept C185592680 @default.
• W1697395551 hasConcept C204787440 @default.
• W1697395551 hasConcept C27081682 @default.
• W1697395551 hasConcept C2777056448 @default.
• W1697395551 hasConcept C2777499811 @default.
• W1697395551 hasConcept C2779442783 @default.
• W1697395551 hasConcept C2780035454 @default.
• W1697395551 hasConcept C2781066024 @default.
• W1697395551 hasConcept C42407357 @default.
• W1697395551 hasConcept C42972112 @default.
• W1697395551 hasConcept C55493867 @default.
• W1697395551 hasConcept C71924100 @default.
• W1697395551 hasConcept C98274493 @default.
• W1697395551 hasConceptScore W1697395551C126322002 @default.
• W1697395551 hasConceptScore W1697395551C142724271 @default.
• W1697395551 hasConceptScore W1697395551C185592680 @default.
• W1697395551 hasConceptScore W1697395551C204787440 @default.
• W1697395551 hasConceptScore W1697395551C27081682 @default.
• W1697395551 hasConceptScore W1697395551C2777056448 @default.
• W1697395551 hasConceptScore W1697395551C2777499811 @default.
• W1697395551 hasConceptScore W1697395551C2779442783 @default.
• W1697395551 hasConceptScore W1697395551C2780035454 @default.
• W1697395551 hasConceptScore W1697395551C2781066024 @default.
• W1697395551 hasConceptScore W1697395551C42407357 @default.
• W1697395551 hasConceptScore W1697395551C42972112 @default.
• W1697395551 hasConceptScore W1697395551C55493867 @default.
• W1697395551 hasConceptScore W1697395551C71924100 @default.
• W1697395551 hasConceptScore W1697395551C98274493 @default.
• W1697395551 hasIssue "6" @default.

• next